Skip to main content

CORRECTION article

Front. Oncol., 06 April 2021
Sec. Cancer Molecular Targets and Therapeutics
Volume 11 - 2021 | https://doi.org/10.3389/fonc.2021.670798

RETRACTED: Corrigendum: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway

A retraction of this article was approved in:

  1. Retraction: Corrigendum: Tan IIA Combined With DDP Inhibits Esophageal Squamous Cell Carcinoma via Down-Regulating the NF-kB/COX-2/VEGF Pathway

    1. Read retraction
\n\n\nXiaozhong Liao\n,,&#x; Xiaozhong Liao 1,2,3†\nYing Gao&#x; Ying Gao1† \n\nJiahui Liu\n,&#x; Jiahui Liu 1,3† \n\nLanting Tao\n Lanting Tao 1\nDongmei Wang Dongmei Wang4\nDan Xie* Dan Xie2* \n\nSuilin Mo\n*\n Suilin Mo 1*
  • 1 Department of Traditional Chinese Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
  • 2 The State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
  • 3 Department of Oncology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China
  • 4 School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Liao X, Gao Y, Liu J, Tao L, Wang D, Xie D and Mo S (2021) Corrigendum: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway. Front. Oncol. 11:670798. doi: 10.3389/fonc.2021.670798

Received: 22 February 2021; Accepted: 09 March 2021;
Published: 06 April 2021; Retracted: 24 June 2021.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.